ArticleJournal of family medicine and primary care2024

The impact of weekly semaglutide, a glucagon-like peptide-1 agonist, on kidney outcomes in adults with type 2 diabetes mellitus.

Ahmad A Algarni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.